The Campbell's Co
CPB
18.90
-0.10
-0.53%
The Campbell's Co
US · CPB
#1953 by market cap
Listed 1970
18.90
-0.10
-0.53%
Live - 5344 symbols - heartbeat 287s ago
· 2026-10-08 08:19
Pre-market
18.97
+0.37%
After-hours
18.92
+0.11%
Overnight
18.98
+0.42%
- Market cap
- 5.65B
- P/E (TTM)i
- 14.43
- P/Bi
- 1.47
- EPSi
- 1.31
- Div yieldi
- 8.25%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on CPB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.50, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -4.96% YoY
Margins
- Gross margin
- 28.14%
- Operating margin
- 10.77%
- Net margin
- 4.14%
Key ratios & quality
- Enterprise valuei
- 12.45B
- Altman Z-Scorei
- 1.50
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.69B | 8.48B | 8.56B | 9.36B | -- | 9.64B | 10.25B | 9.74B |
| Gross profit | 3.00B | 2.81B | 2.63B | 2.92B | -- | 2.97B | 3.12B | 2.74B |
| Selling & admin expenses | 1.57B | 1.42B | 1.35B | 1.47B | -- | 1.57B | 1.60B | 1.55B |
| Research & development | 93.00M | 84.00M | 87.00M | 92.00M | -- | 102.00M | 100.00M | 99.00M |
| Operating profit | 1.29B | 1.27B | 1.15B | 1.31B | -- | 1.23B | 1.35B | 1.05B |
| Pretax profit | 766.00M | 1.34B | 975.00M | 1.13B | -- | 757.00M | 796.00M | 529.00M |
| Tax | 174.00M | 328.00M | 218.00M | 270.00M | -- | 190.00M | 194.00M | 124.00M |
| Net profit | 1.63B | 1.00B | 757.00M | 858.00M | -- | 567.00M | 602.00M | 405.00M |
| Basic EPS | 5 | 3 | 3 | 3 | -- | 2 | 2 | 1 |
| Diluted EPS | 5.36 | 3.29 | 2.51 | 2.85 | -- | 1.89 | 2.01 | 1.31 |
| Line item | 2025-04 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 2.48B | 2.32B | 2.68B | 2.56B | 2.37B | 2.14B |
| Gross profit | 728.00M | 705.00M | 792.00M | 717.00M | 650.00M | 583.00M |
| Selling & admin expenses | 378.00M | 374.00M | 420.00M | 412.00M | 369.00M | 352.00M |
| Research & development | 23.00M | 26.00M | 24.00M | 22.00M | 25.00M | 28.00M |
| Operating profit | 308.00M | 295.00M | 337.00M | 273.00M | 246.00M | 193.00M |
| Pretax profit | 81.00M | 184.00M | 256.00M | 193.00M | 159.00M | -79.00M |
| Tax | 15.00M | 39.00M | 62.00M | 48.00M | 35.00M | -21.00M |
| Net profit | 66.00M | 145.00M | 194.00M | 145.00M | 124.00M | -58.00M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.22 | 0.48 | 0.65 | 0.48 | 0.41 | -0.23 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.39B | 1.70B | 1.96B | 2.06B | -- | 2.19B | 2.23B | 2.72B |
| Cash & ST investments | 859.00M | 69.00M | 109.00M | 189.00M | -- | 108.00M | 132.00M | 394.00M |
| Inventory | 871.00M | 933.00M | 1.25B | 1.29B | -- | 1.39B | 1.42B | 1.61B |
| Total assets | 12.37B | 11.73B | 11.89B | 12.06B | -- | 15.24B | 14.90B | 15.65B |
| Total current liabilities | 3.08B | 1.81B | 2.89B | 2.22B | -- | 3.58B | 2.91B | 3.34B |
| Short-term debt | 1.27B | 102.00M | 876.00M | 261.00M | -- | 1.51B | 858.00M | 1.08B |
| Long-term debt | 4.99B | 4.99B | 3.98B | 4.48B | -- | 5.72B | 6.06B | 6.11B |
| Total liabilities | 9,803,000,000.00 | 8,580,000,000.00 | 8,559,000,000.00 | 8,395,000,000.00 | -- | 11,439,000,000.00 | 10,992,000,000.00 | 11,796,000,000.00 |
| Total equity | 2.57B | 3.15B | 3.33B | 3.66B | -- | 3.80B | 3.90B | 3.85B |
| Retained earnings | 3.19B | 3.74B | 4.04B | 4.45B | -- | 4.57B | 4.69B | 4.62B |
| Line item | 2025-04 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 2.23B | 2.23B | 2.56B | 2.73B | 2.56B | 2.72B |
| Cash & ST investments | 143.00M | 132.00M | 168.00M | 561.00M | 402.00M | 394.00M |
| Inventory | 1.29B | 1.42B | 1.51B | 1.36B | 1.45B | 1.61B |
| Total assets | 14.83B | 14.90B | 15.18B | 15.35B | 15.14B | 15.65B |
| Total current liabilities | 2.85B | 2.91B | 3.13B | 2.69B | 2.95B | 3.34B |
| Short-term debt | 799.00M | 858.00M | 874.00M | 428.00M | 864.00M | 1.08B |
| Long-term debt | 6.10B | 6.06B | 6.10B | 6.65B | 6.15B | 6.11B |
| Total liabilities | 10,956,000,000.00 | 10,992,000,000.00 | 11,220,000,000.00 | 11,341,000,000.00 | 11,112,000,000.00 | 11,796,000,000.00 |
| Total equity | 3.87B | 3.90B | 3.96B | 4.01B | 4.03B | 3.85B |
| Retained earnings | 4.67B | 4.69B | 4.77B | 4.80B | 4.80B | 4.62B |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.40B | 1.04B | 1.18B | 1.14B | -- | 1.19B | 1.13B | 1.04B |
| Depreciation & amortization | 328.00M | 317.00M | 337.00M | 387.00M | -- | 411.00M | 434.00M | 413.00M |
| Free cash flow | 1.10B | 760.00M | 939.00M | 773.00M | -- | 668.00M | 705.00M | 678.00M |
| Dividends paid | -426.00M | -439.00M | -451.00M | -447.00M | -- | -445.00M | -459.00M | -470.00M |
| Stock buybacks / issuance | 23.00M | -34.00M | -164.00M | -120.00M | -- | -65.00M | -62.00M | -26.00M |
| Ending cash balance | 859.00M | 69.00M | 109.00M | 189.00M | -- | 108.00M | 132.00M | 394.00M |
| Line item | 2025-04 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 135.00M | 259.00M | 224.00M | 516.00M | 99.00M | 200.00M |
| Depreciation & amortization | 109.00M | 106.00M | 99.00M | 102.00M | 105.00M | 107.00M |
| Free cash flow | 50.00M | 129.00M | 97.00M | 416.00M | 29.00M | 136.00M |
| Dividends paid | -116.00M | -116.00M | -120.00M | -117.00M | -117.00M | -116.00M |
| Stock buybacks / issuance | -4.00M | -2.00M | -24.00M | -2.00M | 0 | 0 |
| Ending cash balance | 143.00M | 132.00M | 168.00M | 561.00M | 402.00M | 394.00M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 88.82 | 35.07 | 23.35 | -- | 24.54 | 15.21 | 15.64 | 10.40 |
| ROA %i | 12.76 | 8.31 | 6.41 | -- | 7.16 | 4.15 | 4.00 | 2.64 |
| ROIC %i | 20.35 | 13.29 | 10.73 | -- | 11.74 | 7.50 | 7.57 | 5.80 |
| 5-year avg ROE %i | 43.63 | 42.90 | 36.35 | -- | 37.78 | 37.40 | 22.76 | 17.83 |
| EBIT margin %i | 12.78 | 18.24 | 13.60 | -- | 14.06 | 10.44 | 11.13 | 8.83 |
| FCF / sales %i | 12.62 | 8.97 | 10.97 | -- | 8.26 | 6.93 | 6.88 | 6.96 |
| Current ratioi | 0.78 | 0.93 | 0.68 | -- | 0.93 | 0.61 | 0.77 | 0.82 |
| Quick ratioi | 0.47 | 0.37 | 0.23 | -- | 0.32 | 0.21 | 0.25 | 0.29 |
| Debt / assetsi | 52.11 | 45.10 | 42.45 | -- | 41.19 | 49.50 | 48.42 | 47.61 |
| LT debt / equityi | 202.03 | 164.66 | 125.25 | -- | 128.54 | 158.91 | 162.84 | 165.38 |
| Interest coveragei | 3.22 | 7.36 | 6.16 | -- | 7.00 | 4.04 | 3.31 | 2.60 |
| Revenue CAGR (3Y) %i | 14.19 | 8.61 | 1.84 | -- | 2.49 | 4.37 | 6.19 | 1.36 |
| Net income CAGR (3Y) %i | 22.44 | 56.58 | 53.09 | -- | -19.22 | -17.29 | -7.35 | -22.27 |
| FCF CAGR (3Y) %i | 4.91 | -5.41 | -2.53 | -- | -11.01 | -4.21 | -9.11 | -4.28 |
| Line item | 2025-04 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 11.67 | 15.64 | 14.82 | 13.90 | 15.40 | 10.40 |
| ROA %i | 3.02 | 4.00 | 3.69 | 3.52 | 4.06 | 2.64 |
| ROIC %i | 6.39 | 7.57 | 7.25 | 7.06 | 7.87 | 5.80 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.29 | 11.13 | 10.90 | 10.43 | 11.31 | 8.83 |
| FCF / sales %i | 7.07 | 6.88 | 6.76 | 6.89 | 6.76 | 6.96 |
| Current ratioi | 0.78 | 0.77 | 0.82 | 1.01 | 0.87 | 0.82 |
| Quick ratioi | 0.28 | 0.25 | 0.30 | 0.46 | 0.32 | 0.29 |
| Debt / assetsi | 46.51 | 48.42 | 45.93 | 46.10 | 46.30 | 47.61 |
| LT debt / equityi | 157.55 | 162.84 | 154.11 | 165.97 | 152.58 | 165.38 |
| Interest coveragei | 2.76 | 3.31 | 3.27 | 3.14 | 3.39 | 2.60 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Meals & Beverages is the largest reported line at 60.84% of revenue, across 2 reported segments.
- Snacks follows at 39.16%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Meals & Beverages60.84%
Snacks39.16%
Region
U.S operations95.00%
Non-U.S operations5.00%
Quote time 2026-10-08 08:19:23 · For reference only, not investment advice and not tailored to your situation.